Leo M. Budel

1.0k total citations
24 papers, 780 citations indexed

About

Leo M. Budel is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Leo M. Budel has authored 24 papers receiving a total of 780 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pathology and Forensic Medicine, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Immunology. Recurrent topics in Leo M. Budel's work include Lymphoma Diagnosis and Treatment (7 papers), Prostate Cancer Diagnosis and Treatment (4 papers) and Prostate Cancer Treatment and Research (4 papers). Leo M. Budel is often cited by papers focused on Lymphoma Diagnosis and Treatment (7 papers), Prostate Cancer Diagnosis and Treatment (4 papers) and Prostate Cancer Treatment and Research (4 papers). Leo M. Budel collaborates with scholars based in Netherlands, United States and Italy. Leo M. Budel's co-authors include Bob Löwenberg, Glauco Frizzera, Ruud Delwel, Ivo P. Touw, H Hoogerbrugge, K Pouwels, Bachir Alobeid, Laura Milligan, Langxing Pan and T van Agthoven and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Leo M. Budel

24 papers receiving 757 citations

Peers

Countries citing papers authored by Leo M. Budel

Since Specialization

Citations

This map shows the geographic impact of Leo M. Budel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leo M. Budel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leo M. Budel more than expected).

Fields of papers citing papers by Leo M. Budel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leo M. Budel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leo M. Budel. The network helps show where Leo M. Budel may publish in the future.

Co-authorship network of co-authors of Leo M. Budel

This figure shows the co-authorship network connecting the top 25 collaborators of Leo M. Budel. A scholar is included among the top collaborators of Leo M. Budel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leo M. Budel. Leo M. Budel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Uphill versus downhill high-intensity training effectiveness in preserving vascular function and exercise performance in runners who reduce their regular endurance training 2022 ·Sport Sciences for Health ·(unknown), Leo M. Budel, Antonio Cevese, Federico Schena, Cantor Tarperi	1
2	NeuroSAFE in radical prostatectomy increases the rate of nerve‐sparing surgery without affecting oncological outcome 2022 ·British Journal of Urology ·(unknown), Michael A. den Bakker, (unknown), Sebastiaan Remmers, Martijn B. Busstra, M. Gan, Sjoerd Klaver, John Rietbergen, Charlotte F. Kweldam, Mike Kliffen, (unknown), Leo M. Budel, Natascha Goemaere, Jozien Helleman, Chris H. Bangma, Monique J. Roobol, Geert J.L.H. van Leenders, (unknown)	21
3	Inter-observer variability of cribriform architecture and percent Gleason pattern 4 in prostate cancer: relation to clinical outcome 2020 ·Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·(unknown), Eva Hollemans, Michael A. den Bakker, Robert F. Hoedemaeker, Mike Kliffen, Leo M. Budel, Natascha Goemaere, Geert J.L.H. van Leenders	26
4	Intraoperative assessment and reporting of radical prostatectomy specimens to guide nerve‐sparing surgery in prostate cancer patients (NeuroSAFE) 2020 ·Histopathology ·(unknown), Michael A. den Bakker, Sjoerd Klaver, Mike Kliffen, Martijn B. Busstra, John Rietbergen, M. Gan, (unknown), Leo M. Budel, Natascha Goemaere, Chris H. Bangma, Jozien Helleman, Monique J. Roobol, Geert J.L.H. van Leenders	17
5	Validation of Six Nomograms for Predicting Non-sentinel Lymph Node Metastases in a Dutch Breast Cancer Population 2015 ·Annals of Surgical Oncology ·Siem A. Dingemans, Peter D. de Rooij, Roos M. van der Vuurst de Vries, Leo M. Budel, Caroline M. E. Contant, Anne E. M. van der Pool	31
6	Prognostic Relevance of Immunohistochemical Subclassification of Diffuse Large B-Cell Lymphoma in Two Prospective Phase III Clinical Trials 2011 ·Clinical Lymphoma Myeloma & Leukemia ·(unknown), King H. Lam, Bronno van der Holt, (unknown), Dennis Veldhuizen, Leo M. Budel, Andries H. Mulder, Leo F. Verdonck, Ruud Delwel, Daphne de Jong, Gustaaf W. van Imhoff, Pieter Sonneveld	10
7	The chicken chorioallantoic membrane tumor assay as model for qualitative testing of oncolytic adenoviruses 2011 ·Cancer Gene Therapy ·F. Durupt, Danijela Koppers‐Lalic, B. Balme, Leo M. Budel, Olivier Terrier, Bruno Lina, L. Thomas, Rob C. Hoeben, Manuel Rosa‐Calatrava	48
8	The expression of the peripheral cannabinoid receptor CB2 has no effect on clinical outcome in diffuse large B-cell lymphomas 2011 ·European Journal Of Haematology ·(unknown), King H. Lam, Bronno van der Holt, (unknown), Johannes P.T.M. van Leeuwen, Leo M. Budel, Andries H. Mulder, Pieter Sonneveld, Ruud Delwel	6
9	High levels of serum prostate‐specific antigen due to PSA producing follicular non‐Hodgkin’s lymphoma 2007 ·European Journal Of Haematology ·Jan Jelrik Oosterheert, Leo M. Budel, Pieter Vos, Shulamiet Wittebol	7
10	The expression of the Peripheral Cannabinoid receptor on cells of the immune system and Non-Hodgkin's lymphomas 2007 ·Leukemia & lymphoma ·(unknown), King H. Lam, Johannes P.T.M. van Leeuwen, Andries H. Mulder, Leo M. Budel, Bob Löwenberg, Pieter Sonneveld, Ruud Delwel	12
11	The influence of wire localisation for non-palpable breast lesions on visualisation of the sentinel node 2006 ·European Journal of Nuclear Medicine and Molecular Imaging ·(unknown), J. H. Bekker, (unknown), (unknown), (unknown), Leo M. Budel, Lorentz G.B.A. Quekel, John M. H. de Klerk	8
12	Eosinophil-Rich CD30+ Lymphoproliferative Disorder of the Oral Mucosa 2004 ·American Journal of Clinical Pathology ·Bachir Alobeid, Langxing Pan, Laura Milligan, Leo M. Budel, Glauco Frizzera	45
13	Increased sensitivity of B-cell clonality analysis in formalin-fixed and paraffin-embedded B-cell lymphoma samples using an enzyme blend with both 5??3? DNA polymerase and 3??5? exonuclease activity 2003 ·Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·(unknown), Enikő Bagdi, Nicole A. Groen, Leo M. Budel, (unknown), László Krenács, Winand N.M. Dinjens	2
14	Asymmetrical fat embolism 2001 ·The Lancet ·A. K. M. Bartelink, (unknown), Leo M. Budel	8
15	Molecular quantification of viral load in plasma allows for fast and accurate prediction of response to therapy of Epstein–Barr virus‐associated lymphoproliferative disease after allogeneic stem cell transplantation 2001 ·British Journal of Haematology ·Joost W. J. van Esser, Hubert G.M. Niesters, Steven Thijsen, Ellen Meijer, Albert D. M. E. Osterhaus, Katja C. Wolthers, Charles A. Boucher, Jan W. Gratama, Leo M. Budel, Bronno van der Holt, Anton M. van Loon, Bob Löwenberg, Leo F. Verdonck, Jan J. Cornelissen	71
16	Etoposide, mitoxantrone and prednisone: a salvage regimen with low toxicity for refractory or relapsed non-Hodgkin's lymphoma. 2000 ·PubMed ·(unknown), Patty H. Spruit, Bronno van der Holt, M. van't Veer, Leo M. Budel, Bob Löwenberg, Pieter Sonneveld	6
17	Increased proteasome degradation of cyclin-dependent kinase inhibitor p27 is associated with a decreased overall survival in mantle cell lymphoma 2000 ·Blood ·Roberto Chiarle, Leo M. Budel, Jeffrey Skolnik, Glauco Frizzera, Marco Chilosi, (unknown), (unknown), Jory G. Magidson, Alessia Montagnoli, Michele Pagano, Brigitte Maes, Christine De Wolf‐Peeters, Giorgio Inghirami	185
18	Hematopoietic growth factor receptors: structure variations and alternatives of receptor complex formation in normal hematopoiesis and in hematopoietic disorders. 1995 ·PubMed ·Leo M. Budel, Fan Dong, Bob Löwenberg, Ivo P. Touw	11
19	Tumor necrosis factor downregulates granulocyte-colony-stimulating factor receptor expression on human acute myeloid leukemia cells and granulocytes. 1991 ·Journal of Clinical Investigation ·Osama Elbaz, Leo M. Budel, H Hoogerbrugge, Ivo P. Touw, Ruud Delwel, (unknown), Bob Löwenberg	58
20	Interleukin-7 is a growth factor of precursor B and T acute lymphoblastic leukemia 1990 ·Blood ·(unknown), K Pouwels, T van Agthoven, (unknown), Leo M. Budel, H Hoogerbrugge, Ruud Delwel, Raymond G. Goodwin, A E Namen, Bob Löwenberg	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact